COBRE Center for Antimicrobial Resistance and Therapeutic Discovery - Administrative Core

COBRE 抗菌素耐药性和治疗发现中心 - 行政核心

• 批准号: 10488622
• 负责人: ERIKA M D'AGATA
• 金额: $ 45.71万
• 依托单位: MIRIAM HOSPITAL
• 依托单位国家: 美国
• 财政年份: 2018
• 资助国家: 美国
• 起止时间: 2018-09-18 至 2024-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10488622
• 关键词: Advisory Committees; Antimicrobial Resistance; Award; Biological Sciences; Centers of Research Excellence; Communication; Conflict (Psychology); Core Facility; Ensure; Environment; Faculty; Fostering; Funding; Goals; Grant; Hospitals; Individual; Infrastructure; Institution; Laboratories; Mentors; Mission; Monitor; National Institute of General Medical Sciences; Outcome; Peer Review; Performance; Phase; Philosophy; Process; Publications; Research; Research Personnel; Resistance development; Rhode Island; Science; Services; Therapeutic; United States National Institutes of Health; Universities; Work; base; design; drug development; faculty mentor; organizational structure; outreach; professor; programs; senior faculty

The Miriam Hospital enthusiastically recommends Erika D’Agata, MD, MPH of to be appointed as The Center for Antimicrobial Resistance and Therapeutic Discover (CARTD) Program Director/Principal Investigator (PD/PI) effective March 1, 2023. Administrative Core Summary/Abstract The Administrative Core will provide financial, scientific and technologic stewardship of the COBRE Center for Antimicrobial Resistance and Therapeutic Discovery (CARTD) at The Miriam Hospital. Core Director Mylonakis, with the assistance of Deputy Director Nau, will establish overall programmatic goals. These goals and progress toward accomplishing them will be monitored by the Steering Committee, External Advisory Committee, Senior Faculty Mentoring and Advisory Committee (SFMAC) and Program Staff at NIGMS. Our Center’s overall mission is to foster an environment that inspires individuals to pursue rigorous laboratory science by providing technical and mentoring support through our core facilities. We will pursue the following specific aims: (1): The Core will maintain an organizational structure that ensures effective communication between the supervisory, scientific, administrative and service oriented components of the COBRE. (2): The Core will devise strategies to increase the use of CARDT Cores to allow self-sustainability by the end of Phase III. (3): The Core will provide a rigorous mentoring infrastructure to all CARDT principal/pilot investigators. (4): The Core will manage a Pilot Grants Program designed to support the most meritorious research on antimicrobial resistance and drug development.

Miriam医院热情地推荐MPH的Erika D'Agata，被任命为抗菌抗药性和治疗发现中心（CARTD）计划主管/首席研究员（PD/PI），自2023年3月1日生效。 行政核心 摘要/摘要 行政核心将提供财务，科学和技术管理 Miriam的抗菌耐药性和治疗发现（CARTD）的鞋垫中心 医院。核心董事Mylonakis在副局长NAU的协助下建立 总体程序化目标。这些目标和实现目标的进步将是 由指导委员会，外部咨询委员会，高级教职员工指导的监视 NIGMS的咨询委员会（SFMAC）和计划人员。我们中心的整体任务是 为了促进一个激发个人纯化严格实验室科学科学的环境 通过我们的核心设施提供技术和心理支持。我们将追求 以下特定目的：（1）：核心将保持一个组织结构，以确保 监督，科学，行政和服务的有效沟通 毛绒的组成部分。 （2）：核心将制定策略以增加Cardt的使用 在第三阶段结束时允许自我可持续性的核心。 （3）：核心将提供严格的 向所有CARDT主要/飞行员调查员指导基础设施。 （4）：核心将管理一个 飞行员赠款计划旨在支持最有功的抗菌研究 抗药性和药物发展。